Prenylated flavonoids are natural products that exhibit diverse biological effects and often represent the active components of various medicinal plants. This study demonstrated the production of prenylated naringenin by biotransformation using transgenic yeast expressing naringenin 8-dimethylallyltransferase, a membrane-bound enzyme, without feeding of prenyl donors. This method provides the possibility of generating prenylated flavonoids that occur rarely in nature.
Prenylated aromatic secondary metabolites, such as coumarins, flavonoids, and xanthones, are widely distributed in the plant kingdom, and many of them are thought to function as protectants for plants by exhibiting strong antibacterial and antifungal activities. 1, 2) In addition, prenylated flavonoids have been identified as active components of various medicinal plants, showing a variety of biological activities, such as antimicrobial, antitumor, anti-androgen, anti-leishmania, and anti-NO production. [3] [4] [5] [6] Due to these beneficial effects on human health, prenylated flavonoids draw the substantial interest of many researchers as lead compounds for new drugs and for applications in functional foods. It is noteworthy that the prenyl moieties are crucial to these biological activities, [7] [8] [9] and therefore flavonoid prenyltransferases are an attractive target for metabolic engineering to produce valuable compounds economically in transgenic systems.
In a previous study, we isolated a naringenin 8-dimethylallyltransferase cDNA (SfN8DT-1) encoding a membrane-bound enzyme from Sophora flavescens, 10) which is responsible for the prenylation of naringenin at the 8-position. SfN8DT-1 shows strict substrate and product specificities, including the prenylation position in the flavonoid core. These enzymatic features of SfN8DT-1 are suitable for the production of one particular prenylated flavonoid without byproducts with similar structures. In addition, the product of SfN8DT-1, 8-dimethylallylnaringenin (8DN), is one of the most potent phytoestrogens, 11) and it has significant potential to be applied in cosmetics and food supplements. This study reports the first example of biotransformation to produce prenylated flavonoids using transgenic yeast overexpressing SfN8DT-1, a membrane-bound enzyme, as a new method of supplying these valuable natural products.
The full-length SfN8DT-1 cDNA was subcloned into a yeast expression vector (pDR196) under the control of the strong constitutive promoter PMA1 to yield pDR-SfN8DT-1.
10) The plasmid pDR-SfN8DT-1 was introduced into yeast strain W303-1A-Ácoq2, which contained a disrupted copy of the COQ2 gene, 12) because this strain was unable to utilize prenyl diphosphate for ubiquinone synthesis and therefore was expected to provide a prenyl donor efficiently for prenylation of the flavonoids. The yeast transformant was pre-cultured in SD (-uracil) medium (yeast nitrogen base without amino acids, yeast synthetic drop-out medium without uracil, 2% glucose) (30 ml) at 30 C for 20 h. When the precultured yeast suspension (2 ml) was inoculated into fresh medium (30 ml) for biotransformation, (2RS)-naringenin (Extrasynthese, Genay Cedex, France) was simultaneously added to the culture medium (final concentration, 0.1 mM), and then the yeast cells were further incubated for 12 h under the same conditions. After harvesting the culture medium was collected by centrifugation, and the cells were lysed with Zymolyase 20T (5 mg/ml, 10 ml) (Seikagaku, Tokyo). Then the culture medium and cells were extracted with ethyl acetate (15 ml) 3 times, and the combined ethyl acetate soluble portion was evaporated to dryness. To analyze the compounds produced, the ethyl acetate extract was dissolved in methanol (100 ml), and this was then injected into a LC/ESI-MS 2010A system (Shimadzu, Kyoto, Japan; column LiChrosphere 100RP-18, 4 Â 250 mm Merck, Tokyo; solvent system, methanol-H 2 O-formic acid (80:20:0.3); flow rate, 0.2 ml min À1 ). The reaction product, 8DN, was detected in the culture medium of SfN8DT-1 transgenic yeast, which showed a retention time and a molecular mass identical to the parent ion of standard 8DN in LC/ESI(+)-MS analysis (Fig. 1A) . Standard specimens of 6-dimethyallylnaringenin and 3 0 -dimethylalyllnaringenin showed retention times apparently different from 8DN. 10) This product was detected neither in the yeast cells expressing SfN8DT-1 nor in the culture medium of control yeast cells with an empty vector (Fig. 1B) , whereas naringenin was detected in the cells expressing SfN8DT-1 (21:9 AE 2:7 mg/g of fresh weight). This result indicates that the transgenic yeast can provide the prenyl substrate (dimethylallyl pyrophosphate) in vivo, and recombinant y To whom correspondence should be addressed. Fax: +81-774-38-3623; E-mail: yazaki@rish.kyoto-u.ac.jp Abbreviations: 8DN, 8-dimethylallylnaringenin; SfN8DT-1, Sophora flavescens naringenin 8-dimethylallyltransferase SfN8DT-1 converted naringenin to its prenylated form. It also suggests that most of the biotransformed product was released into the medium, which is a property beneficial for the effective recovery of the product.
The product accumulation pattern was traced during the culture period in a time-course experiment, where 0.1 mM naringenin was supplied at the beginning of culture. The reaction product was analyzed quantitatively by HPLC with a Shimadzu LC-10A system. The solvent system consisted of water containing 0.3% acetic acid (solvent A) and methanol with 0.3% acetic acid (solvent B), and the following linear gradient program was used: 50% buffer B (0 to 5 min); 50 to 65% linear gradient buffer B (5 to 10 min); 65 to 100% linear gradient buffer B (10 to 25 min); 100% buffer B (20 to 30 min); constant flow-rate of 1 ml min À1 . Naringenin and 8DN were eluted at 9.3 min and 18.7 min respectively. As an internal standard, 2 0 -hydroxychalcone (Extrasynthese; retention time, 23.1 min) was used, because this compound was easy available and its retention time did not overlap those of other compounds in HPLC analysis. The reaction product was monitored at 294 nm. As Fig. 2A shows, the prenylated product appeared later than 5 h after inoculation of the cells and increased with cell growth.
To determine the optimum concentration of flavonoid substrate, various concentrations of naringenin were simultaneously added when pre-cultured yeast suspension was inoculated into fresh medium, and then the yeast cells were further incubated for 12 h. Biotransformation activity was monitored, as shown in Fig. 2B . Within this time period, the prenylation reaction was saturated with 0.2-0.3 mM (final concentration) of the substrate. When the final concentration of naringenin in the medium was higher than 0.4 mM, yeast growth was apparently suppressed with decreased production of 8DN.
Next, 8DN productivity was examined in two different media, selection medium SD (-uracil) and a nonselective medium, YPD (1% yeast extract, 1% peptone, 2% glucose). When the pre-cultured yeast suspension in SD (-uracil) medium was inoculated into SD (-uracil) or YPD medium for biotransformation, naringenin was simultaneously added to the culture medium (final concentration, 0.1 mM), and then the yeast cells were further incubated for 12 h. Yeast cells cultivated in YPD medium showed converting activity from naringenin to C after the addition of naringenin. The medium was extracted with ethyl acetate, and the 8DN (white circle) produced was quantified by HPLC analysis. Yeast growth (black circle) was evaluated by measurement of the optical density at 600 nm. All experiments were replicated 3 times, and the standard deviation is shown.
8DN, as observed for the cells grown in SD (-uracil) medium, although 8DN productivity in the YPD medium was about 44-60% as compared to the SD (-uracil) medium (Table 1 ). It is suggested that yeast cells grown in non-selective medium might gradually lose the plasmid during the cultivation period due to rapid cell division, whereas the growth rate is better in YPD than in SD (-uracil) medium. SD (-uracil) medium was thus suitable for 8DN production, and the maximum yield, of 8DN, was obtained when 0.2 mM naringenin was added, whereas the best biotransformation rate was 1.9% with 0.05 mM naringenin addition. To increase biotransformation efficiency, further improvements are necessary.
In a previous study, Arabidopsis plants were transformed with full-length SfN8DT-1 cDNA and the prenylated flavonoid contents were analyzed in transgenic seedlings. 10) When the prenylated flavonoid production of transgenic Arabidopsis was compared with that of transgenic yeast, transgenic Arabidopsis seedlings accumulated about 0.5 mg/100 mg of dry weight, which corresponded to about 3 ml of the culture of transgenic yeast in the present study. The transgenic Arabidopsis, in addition to 8DN, produced 8-dimethylallylkaempferol as well as dimethylallylated apigenin and quercetin as byproducts, probably via in vivo conversion by endogenous flavonoid biosynthetic enzymes. These results suggest that transgenic yeast provides a method suitable for the production of the potent phytoestrogen 8DN.
In general, biotransformation in transgenic microorganisms and their ability to release products provide an alternative method of supplying valuable natural products that occur at low levels in nature, instead of chemical synthesis. For economical production of 8DN, further attempts are necessary to increase its productivity by thorough optimization of growth mediums, selection of host strains, alteration of codon usage, etc., but as the first example of the production of prenylated flavonoids using a membrane-bound prenyltransferase of plant origin, this study indicates the potential of transgenic yeast for the production of plant metabolites. Further studies to isolate novel genes coding for flavonoid prenyltransferases that have different specificities for both substrates and products should expand the possibilities of supplying divergent prenylated flavonoids by biotransformation using yeast transformants. Transgenic yeast cells were cultured in SD (-uracil) or YPD medium for 12 h at 30 C after the addition of naringenin (final concentration, 0.05, 0.1, or 0.2 mM). The medium was separated from the cells and extracted with ethyl acetate. 8DN productivity was evaluated by HPLC analysis, and yeast growth was evaluated by measurement of the optical density at 600 nm (OD 600 ). Values are the mean AE standard deviation for three replicates.
